News

Professor Gordon Liu, a leading expert on health and development economics, health policy reform, and pharmaceutical economics in China, and a key figure in Chinese health care reform efforts, has joined Analysis Group as an academic affiliate.

"We are delighted to welcome Dr. Liu to our distinguished group of health care experts," said Analysis Group President and CEO Martha S. Samuelson. "He brings a deep knowledge of international health care policy and economics to our practice – a perspective that is critical as we respond to clients’ growing needs for high-quality analyses in China."

Dr. Liu is a professor of economics and the director of China Center for Health Economics Research at Peking University’s Guanghua School of Management. He has undertaken multiple research projects funded by the State Council Health Reform Office, the National Science Foundation, UNICEF, the World Bank, and the China Medical Board. He serves on the State Council Health Reform Advisory Commission and is president of the Chinese Society for Pharmacoeconomics and Outcomes Research. He previously served as president of the Chinese Economists Society and was the founding chair of the Asian Consortium for the International Society for Pharmacoeconomics and Outcomes Research (ISPOR).

"Dr. Liu’s multifaceted understanding of China’s health care reform efforts and the country’s pharmaceuticals market will complement and strengthen Analysis Group’s research capabilities and further our goal of providing high-quality consulting services globally," said Analysis Group Managing Principal Eric Q. Wu.

Read the press release